We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NXDR:NYSENextdoor Holdings, Inc. Analysis

Data as of 2026-08-23 - not real-time

$2.39

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Nextdoor Holdings, Inc. trades at $2.39, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. RSI sits at 47.5, which reads as neutral, and MACD momentum is bearish. Recent trading has carved out support near $2.18 and resistance around $2.71.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Analyst price targets sit 40.2% above the current price. Revenue is growing at 14.5% on a -11.1% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 44.0%, a beta of 1.35 and a maximum drawdown of 50.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons diverge: buy near-term but hold on a long view, at 3/10 conviction over the longer horizon.

Top Market Events

Seeking Alpha18dNextdoor forecasts low teens 2026 revenue growth and ~10% adjusted EBITDA margin as Q3 revenue is...Updated Aug 4, 2026 0 SAN FRANCISCO-- BUSINESS WIRE --Aug 4, 2026-- Nextdoor Holdings, Inc.Seeking Alpha18dNextdoor Holdings, Inc. NXDR Q2 2026 Earnings Call TranscriptGood morning. My name is Leah, and I will...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 1.94
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 1.94
  • Analyst targets imply +40.2% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • Negative profit margin of -11.1%
  • Analyst targets imply +40.2% versus the current price
  • Negative return on equity of -7.2%

Key Metrics & Analysis

Financial Health

Revenue Growth14.50%
Profit Margin-11.08%
P/E Ratio-65.2
ROE-7.24%
ROA-5.36%
Debt/Equity6.75
P/B Ratio2.2
Op. Cash Flow$12.8M
Free Cash Flow$22.9M
Industry P/E16.1

Technical Analysis

TrendBullish
RSI47.5
Support$2.18
Resistance$2.71
MA 20$2.44
MA 50$2.34
MA 200$1.94
MACDBearish
VolumeDecreasing
Fear & Greed Index94.41

Valuation

Fair Value$2.32
Target Price$3.35
Upside/Downside40.17%
GradeFair
TypeBlend

Risk Assessment

Beta1.35
Volatility43.96%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.